Exploring MicroRNA Expression Profiles Related to the mTOR Signaling Pathway in Mouse Embryonic Fibroblast Cells

Chia-Wei Lin, Ming-Shiou Jan, Jung-Hua Steven Kuo1

  • 1§Department of Pharmacy, Chia Nan University of Pharmacy and Science, 60 Erh-Jen Road, Section 1, Jen-Te, Tainan 717, Taiwan.

Insights

Poly(ethylenimine) (PEI) affects microRNA (miRNA) expression, leading to decreased cell viability and inhibited mTOR signaling. This study reveals PEI

Area of Science:

  • Molecular Biology
  • Toxicology
  • Gene Regulation

Background:

  • Poly(ethylenimine) (PEI) toxicology is known at the gene expression level.
  • The impact of PEI on microRNA (miRNA) expression, which regulates post-transcriptional gene expression, is largely unknown.

Purpose of the Study:

  • To investigate the effects of PEI on miRNA expression profiles related to cell death.
  • To explore the role of specific miRNAs in PEI-induced cellular responses.

Main Methods:

  • Microarray analysis of miRNA expression in mouse embryonic fibroblast (MEF) cells treated with PEI.
  • Real-time quantitative reverse transcriptase-polymerase chain reaction (RT-qPCR) for miRNA verification.
  • Analysis of target gene (Igf1) and protein expression.
  • Assessment of mTOR signaling pathway activity and autophagy induction.

Main Results:

  • PEI treatment upregulated three specific miRNAs (mmu-miR-3090-5p, mmu-miR-346-3p, mmu-miR-494-3p) in MEF cells.
  • These miRNAs decreased gene and protein expression of the growth factor Igf1.
  • PEI treatment inhibited the mTOR signaling pathway via autophagy induction.
  • Cell viability decreased in PEI-treated cells and cells transfected with the upregulated miRNA mimics.

Conclusions:

  • PEI influences miRNA expression, impacting cell death mechanisms.
  • The mTOR signaling pathway and cell viability are affected by PEI-induced miRNA changes.
  • PEI may regulate target cell miRNA expression, contributing to its toxicological effects.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K